Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
May 31, 2019 08:30 ET | Genprex, Inc.
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully...
Cannabis Science logo.png
Cannabis Science Set to Participate in the Premier Event Focused on High-Impact Global Collaborations; The Global Health Catalyst Summit at Harvard Medical School Starts Today
May 24, 2019 07:53 ET | Cannabis Science, Inc.
IRVINE, CA, May 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
SEngine Precision Medicine Announces Renowned Medicinal Chemist to Join Scientific Advisory Board
April 25, 2019 09:15 ET | SEngine Precision Medicine
SEATTLE, April 25, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology startup accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS Test®, today...
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
April 12, 2019 09:00 ET | Genprex, Inc.
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene...
Mountain America senior leadership team presents a $56,000 check to David Huntsman, who represented Huntsman Cancer Foundation, at the Utah Jazz game on April 9, 2019.
Mountain America Credit Union Donates $56,000 to Huntsman Cancer Foundation
April 11, 2019 10:00 ET | Mountain America Credit Union
SANDY, Utah, April 11, 2019 (GLOBE NEWSWIRE) -- As the 2018-19 Utah Jazz regular season comes to a close, Mountain America Credit Union presented Huntsman Cancer Foundation with a $56,000 check as...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
April 11, 2019 08:30 ET | Genprex, Inc.
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
PremierBiomedical-Logo-FINAL.jpg
Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects
February 20, 2019 08:30 ET | Premier Biomedical, Inc.
PHOENIX, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Premier Biomedical, Inc. (BIEI), a research-based publicly traded company that intends to discover and develop...
BioAffinity.jpg
bioAffinity Technologies Announces Award of Canadian Patent
February 04, 2019 12:25 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...
Celebrating the launch of USC-Olympus Innovation Partnership
The Future of Cancer Diagnostics and Treatment: New Partnership Bringing Transformation to Precision Cancer Medicine
January 08, 2019 11:30 ET | Olympus
WALTHAM, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- The University of Southern California and Olympus have announced their first-ever co-development partnership with the goal of advancing multiscale...
PremierBiomedical-Logo-FINAL.jpg
Uptick Newswire Hosts the CEO of Premier Biomedical, Inc. to Talk About Exciting Deals on the Horizon with Distributors and the Launch of New Products in 2019
December 20, 2018 07:30 ET | Premier Biomedical, Inc.
PHOENIX, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast features Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”), a research-based publicly traded company that intends to...